| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.34 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.06 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.16 | 0.3 |